Clinical Trial: A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function

U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07137689) titled 'A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function' on Aug. 17.

Brief Summary: The purpose of this study is to help determine the right dose of LY3537982 in participants with kidney problems, particularly those with severe kidney problems. The study will last about 43 days for each participant.

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Renal Insufficiency

Intervention: DRUG: LY3537982

Administered orally

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Eli Lilly and Company

Published by HT Digital Content Services with permission from Hea...